EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Development of a human peripheral blood ex vivo model for rapid protein biomarker detection and applications to radiation biodosimetry

Leah Nemzow iD, Thomas Boehringer, Bezalel Bacon iD, Helen C Turner

PLOS ONE · 2023

DOI: 10.1371/journal.pone.0289634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2023. Verfasst von Leah Nemzow und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Radiological Research, Columbia University Irving Medical Center, New York, New York, United States of America. Hauptthemen laut MEDLINE: Lymphocytes, Primates. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the event of a widespread radiological incident, thousands of people may be exposed to a wide range of ionizing radiation. In this unfortunate scenario, there will be a need to quickly screen a large number of people to assess the amount of radiation exposure and triage for medical treatment. In our earlier work, we previously identified and validated a panel of radiosensitive protein biomarkers in blood leukocytes, using the humanized-mouse and non-human primate (NHP) models. The objective of this work was to develop a high-throughput imaging flow-cytometry (IFC) based assay for the rapid measurement of protein biomarker expression in human peripheral blood samples irradiated ex vivo . In this assay design, peripheral human blood samples from healthy adult donors were exposed to 0–5 Gy X-irradiation ex vivo and cultured for up to 2 days. Samples were stained with a cocktail of surface antigens (CD66b, CD20, and CD3), fixed and permeabilized, and intracellularly stained for BAX (Bcl-2-associated X) protein, used here as a representative biomarker. Samples were interrogated by IFC, and a uniform analysis template was created to measure biomarker expression in heterogeneous and specific leukocyte subtype populations at each time point. In this human blood ex vivo model, we show that within gated populations of leukocyte subtypes, B-cells are highly radiosensitive with the smallest surviving fraction, followed by T-cells and granulocytes. Dose-dependent biomarker responses were measured in the lymphocytes, B-, and T-cell populations, but not in the granulocytes, with dose-response curves showing increasing fold changes in BAX protein expression up to Day 2 in lymphocyte populations. We present here the successful use of this ex vivo model for the development of radiation dose-response curves of a candidate protein biomarker towards future applications of dose reconstruction and biodosimetry.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphocytesPrimatesAdultHumansAnimalsMiceDose-Response Relationship, RadiationRadiation DosageBiomarkersRadiometry

Substanzen

Biomarkers

Autor:innen und Institutionen

  • Center for Radiological Research, Columbia University Irving Medical Center, New York, New York, United States of America.

ORCID-Profile: Leah Nemzow, Bezalel Bacon

Förderung

  • NIAID NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases

Zitieren

APA

Nemzow, L., Boehringer, T., Bacon, B., & Turner, H. C. (2023). Development of a human peripheral blood ex vivo model for rapid protein biomarker detection and applications to radiation biodosimetry. PLOS ONE. https://doi.org/10.1371/journal.pone.0289634

Vancouver

Nemzow L, Boehringer T, Bacon B, Turner HC. Development of a human peripheral blood ex vivo model for rapid protein biomarker detection and applications to radiation biodosimetry. PLOS ONE. 2023. doi:10.1371/journal.pone.0289634

BibTeX
@article{Nemzow2023,
  author = {Nemzow, Leah and Boehringer, Thomas and Bacon, Bezalel and Turner, Helen C},
  title = {Development of a human peripheral blood ex vivo model for rapid protein biomarker detection and applications to radiation biodosimetry},
  journal = {PLOS ONE},
  year = {2023},
  doi = {10.1371/journal.pone.0289634}
}
Kostenlos starten →